Improved Alveolar Dynamics and Structure After Alveolar Epithelial Type II Cell Transplantation in Bleomycin Induced Lung Fibrosis
Alveolar Type II Cells or Mesenchymal Stem Cells: Comparison of Two Different Cell Therapies for the Treatment of Acute Lung Injury in Rats
Induced Pluripotent Stem Cell-Derived Lung Alveolar Epithelial Type II Cells Reduce Damage in Bleomycin-Induced Lung Fibrosis
Cell Therapy in Idiopathic Pulmonary Fibrosis
Intratracheal instillation of alveolar type II cells enhances recovery from acute lung injury in rats.
Lung surfactant metabolism: early in life, early in disease and target in cell therapy.
Safety and Tolerability of Alveolar Type II Cell Transplantation in Idiopathic Pulmonary Fibrosis
Surfactant Protein A Prevents IFN-γ/IFN-γ Receptor Interaction and Attenuates Classical Activation of Human Alveolar Macrophages
A new experimental model of acid- and endotoxin-induced acute lung injury in rats
''PIRFENIDONE FOR THE TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS.''
''GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF IDIOPATHIC PULMONARY FIBROSIS''
''LOSARTAN PREVENTS HEART FIBROSIS INDUCED BY LONG-TERM INTENSIVE EXERCISE IN AN ANIMAL MODEL.''
''ROLE OF TETRAHYDROBIOPTERIN IN PULMONARY VASCULAR REMODELLING ASSOCIATED WITH PULMONARY FIBROSIS.''
''ALVEOLAR EPITHELIAL CELL INJURY AS AN ETIOPATHOGENIC FACTOR IN PULMONARY FIBROSIS.''
''CARDIAC ARRHYTHMOGENIC REMODELING IN A RAT MODEL OF LONG-TERM INTENSIVE EXERCISE TRAINING.''
''ACTIVATION OF LUNG MACROPHAGE SUBPOPULATIONS IN EXPERIMENTAL ACUTE PANCREATITIS.''
SINGLE AND REPEATED BLEOMYCIN INTRATRACHEAL INSTILLATIONS LEAD TO DIFFERENT BIOMECHANICAL CHANGES IN LUNG TISSUE.
BIOLOGICAL CONSEQUENCES OF OXYGEN DESATURATION AND RESPIRATORY EFFORT IN AN ACUTE ANIMAL MODEL OF OBSTRUCTIVE SLEEP APNEA (OSA)